Aclarion, Inc. (ACON) Executive Compensation
Aclarion, Inc. (ACON) is a publicly traded company on the Nasdaq, categorized under SIC 8071 (Services-Medical Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACON
CIK: 1635077
Exchange: Nasdaq
SIC 8071: Services-Medical Laboratories
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haynie & Company
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerBenjamin Brown
Audit LocationSalt Lake City, Utah, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-19 | 2026-08-17 | 4 Filing | 0001683168-26-006576 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001683168-26-006545 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001683168-26-006516 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001683168-26-006514 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001683168-26-006513 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-13 | 4 Filing | 0001683168-26-006512 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006026 | View SEC Doc Filr Page |
| S-8 | 2026-07-09 | — | REGISTRATION STATEMENT | 0001683168-26-005372 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004815 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004814 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004812 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004813 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004811 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004810 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004807 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004809 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | 4 Filing | 0001683168-26-004806 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | CURRENT REPORT | 0001683168-26-004565 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q FOR MAR 2026 | 0001683168-26-003822 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-12 | 4 Filing | 0001683168-26-003744 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-11 | 4 Filing | 0001683168-26-003694 | View SEC Doc Filr Page |
| 4 | 2026-05-11 | 2026-05-11 | 4 Filing | 0001683168-26-003676 | View SEC Doc Filr Page |
| 4 | 2026-05-08 | 2026-05-06 | 4 Filing | 0001683168-26-003610 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-04 | NOTICE AND PROXY STATEMENT | 0001683168-26-003236 | View SEC Doc Filr Page |
| 8-K | 2026-04-22 | 2026-04-21 | FORM 8-K | 0001683168-26-003124 | View SEC Doc Filr Page |